HC Wainwright & Co. Reiterates Buy on Precision BioSciences, Maintains $60 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 91.4%

Neg 0% Neu 91.4% Pos 0%

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Precision BioSciences (NASDAQ:DTIL) with a Buy and maintains $60 price target.